Imaging pulmonary emboli and deep venous thrombi with 99mTc- bitistatin, a platelet-binding polypeptide from viper venom

Journal of Nuclear Medicine

Volumn 41, Issue 6, 2000, Pages 1056-1064

  Knight, Linda C ^a   Baidoo, Kwamena E ^b   Romano, Jan E ^b   Gabriel, Jerome L ^b   Maurer, Alan H ^b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

99mTc bitistatin; Deep venous thrombosis; Pulmonary embolism, direct visualization with 99mTc bitistatin; Thrombosis imaging with 99mTc bitistatin

Indexed keywords

BITISTATIN; POLYPEPTIDE; TECHNETIUM 99M; VIPER VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DOG; DRUG UPTAKE; IMAGE QUALITY; ISOTOPE LABELING; LUNG EMBOLISM; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DOGS; HUMANS; IODINE RADIOISOTOPES; ORGANOTECHNETIUM COMPOUNDS; PEPTIDES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PULMONARY EMBOLISM; RADIOPHARMACEUTICALS; VENOUS THROMBOSIS; VIPER VENOMS;

EID: 0034042568     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Freiman DG. The structure of thrombi. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott: 1987:1123-1135.
2. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIlb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood. 1996;88:907-914.
3. Bai Y, Durbin H, Hogg N. Monoclonal antibodies specific for platelet glycoproteins react with human monocytes. Blood. 1984;64:139-146.
4. Coller BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of platelet GPIlb/IIIa complex. J Clin Invest. 1985;76:101-108.
5. Hanson SR, Pareti FI, Ruggeri ZM, et al. Effects of monoclonal antibodies against the platelet glycoptotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. J Clin Invest. 1988;81:149-158.
6. Oster ZH, Srivastava SC, Som P, et al. Thrombus radioimmunoscintigraphy: an approach using monoclonal antiplatelet antibody. Proc Natl Acad Sci USA. 1985;82:3465-3468.
7. Peters AM, Lavender JP, Needham SG, et al. Imaging thrombus with radiolabelled monoclonal antibody to platelets. Br Med J. 1986;293:1525-1527.
8. Muto P, Lastoria S, Varrella P, et al. Detecting deep venous thrombosis with technetium-99m-labeled synthetic peptide P280. J Nucl Med. 1995;36:1384-1391.
9. Knight LC, Radcliffe R, Maurer AH, Rodwell JD, Alvarez VL. Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets. J Nucl Med. 1994;35:282-288.
10. Lister-James J, Knight LC, Maurer AH, Bush LR, Moyer BR, Dean RT Thrombus imaging with a technetium-99m-labeled, activated platelet receptor-binding peptide. J Nucl Med. 1996;37:775-781.
11. Niewiarowski S, McLane MA, Kloczewiak M, Stewart GJ. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol. 1994;31:289-300.
12. Gould RJ, Polokoff MA, Friedman PA, et al. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med. 1990;195:168-171.
13. Blobel CP, White JM. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr Opin Cell Biol. 1992;4:760-765.
14. Shebuski RJ, Ramjit DR, Bencen GH, Polokoff MA. Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper Bitis arietans. J Biol Chem. 1989;264:21550-21556.
15. Shigeta O, Gluszko P, Downing SW, Lu W, Niewiarowski S, Edmunds LH. Protection of platelets during long-term extracorporeal membrane oxygenation in sheep with a single dose of a disintegrin. Circulation. 1992;86(suppl II):II398-II404.
16. Knight LC, Maurer AH, Romano JE. Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model. J Nucl Med. 1996;37:476-482.
17. Adler M, Lazarus RA, Dennis MS, Wagner G. Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist. Science. 1991;253: 445-448.
18. Adler M, Carter P, Lazarus RA, Wagner G. Cysteine pairing in the glycoprotein IIbIIIa antagonist kistrin using NMR, chemical analysis, and structure calculations. Biochemistry. 1993;32:282-289.
19. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984;12:387-395.
20. Calvete JJ, Schrader M, Raida M. McLane MA, Romero A, Niewiarowski S. The disulphide bond pattern of bitistatin, a disintegrin isolated from the venom of the viper Bitis arietans. FEBS Lett. 1997;416:197-202.
21. 125I-containing acylating agent. Biochem J. 1973;133:529-539.
22. 125I]iodide following iodination of protein solutions. Anal Biochem. 1980;106:118-122.
23. Abrams MJ, Juweid M, tenKate CI, et al. Techmetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med. 1990;31:2022-2028.
24. King T, Zhao S, Lan T. Preparation of protein conjugates via intermolecular hydrazone linkage. Biochemistry. 1986;25:5774-5779.
25. Savage B, Marzec UM, Chao BH, Harker LA, Maragonore JM, Ruggieri ZM. Binding of the snake venom-derived proteins applagin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. J Biol Chem. 1990;265:11766-11772.
26. Burt DR. Receptor binding methodology and analysis. In: O'Brien RA. ed. Receptor Binding in Drug Research. New York, NY: Marcel Dekker; 1986:4-29.
27. Institute of Laboratory Animal Resources, National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press: 1996.
28. Mather SJ, Ellison D. Reduction-mediated technetium-99m labeling of monoclonal antibodies. J Nucl Med. 1990;31:692-697.
29. Steigman J, Eckelman WC. The Chemistry of Technetium in Medicine. Washington, DC: National Academy Press: 1992:106-108.
30. Gaudriault G, Vincent JP. Selective labeling of alpha- or epsilon-amino groups in peptides by the Bolton-Hunter reagent. Peptides. 1992;13:1187-1192.
31. McLane MA, Kowalska MA, Silver L, Shattil SJ, Niewiarowski S. Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets. Biochemical J. 1994;301:429-436.
32. 3-targeted radioligands. Thromb Haemost. 1998;80:845-851.
33. 99mTc monoclonal antifibrin antibody. Circulation. 1992;85:298-304.
34. DeNardo SJ, DeNardo GL. Iodine-123 fibrinogen scintigraphy. Semin Nucl Med. 1977;7:245-251.
35. m hexamethylpropyleneamineoxime (HMPAO) as a platelet label: evaluation of labelling parameters and first in vivo results. Nucl Med Commun. 1988;9:831-842.
36. 99mTc-antifibrin Fab' fragments for imaging venous thrombi: evaluation in a canine model. Radiology. 1989;173:163-169.